STAT

STAT+: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field

STAT+: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the fieldWorldPing

The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines. They could also have a chilling effect across the industry.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

More coverage: all health news on WorldPing.

Related news